ibuprofen has been researched along with Muscular Dystrophy in 2 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "We designed two Phase I studies that assessed healthy volunteers in order to evaluate the safety and to optimize the dosing of the combination of the drugs isosorbide dinitrate, a nitric oxide donor, and ibuprofen, a nonsteroidal antiinflammatory drug." | 6.79 | Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers. ( Baldelli, S; Capetti, A; Cattaneo, D; Clementi, E; Cossu, MV; Cozzi, V; Fucile, S; Pellegrino, P, 2014) |
| "This open-label, single centre pilot study was designed to evaluate safety and tolerability of the combination of the drugs isosorbide dinitrate, a nitric oxide donor, and ibuprofen, a non steroid anti-inflammatory drug, in a cohort of adult dystrophic patients (Duchenne, Becker and Limb-Girdle Muscular Dystrophy)." | 5.16 | Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients. ( Bonato, S; Bresolin, N; Brighina, E; Brunelli, S; Cattaneo, D; Clementi, E; Comi, GP; D'Angelo, MG; Gandossini, S; Magri, F; Martinelli Boneschi, F; Sciorati, C; Stefanoni, G; Turconi, AC, 2012) |
| "We designed two Phase I studies that assessed healthy volunteers in order to evaluate the safety and to optimize the dosing of the combination of the drugs isosorbide dinitrate, a nitric oxide donor, and ibuprofen, a nonsteroidal antiinflammatory drug." | 2.79 | Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers. ( Baldelli, S; Capetti, A; Cattaneo, D; Clementi, E; Cossu, MV; Cozzi, V; Fucile, S; Pellegrino, P, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cossu, MV | 1 |
| Cattaneo, D | 2 |
| Fucile, S | 1 |
| Pellegrino, P | 1 |
| Baldelli, S | 1 |
| Cozzi, V | 1 |
| Capetti, A | 1 |
| Clementi, E | 2 |
| D'Angelo, MG | 1 |
| Gandossini, S | 1 |
| Martinelli Boneschi, F | 1 |
| Sciorati, C | 1 |
| Bonato, S | 1 |
| Brighina, E | 1 |
| Comi, GP | 1 |
| Turconi, AC | 1 |
| Magri, F | 1 |
| Stefanoni, G | 1 |
| Brunelli, S | 1 |
| Bresolin, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Renal Ageing-sarcopenia Network: a Combined Genetic, Immunological and Psychological Approach to Dissect Frailty[NCT04630132] | 1,500 participants (Anticipated) | Observational | 2017-03-25 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for ibuprofen and Muscular Dystrophy
| Article | Year |
|---|---|
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Female; Healthy Volunteers; Huma | 2014 |
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Ibuprofen; Isosorbide Di | 2012 |